Biological role of the N-formyl peptide receptors

Immunopharmacology and Immunotoxicology

Volumn 28, Issue 1, 2006, Pages 103-127

  Panaro, M A ^a   Acquafredda, A ^a   Sisto, M ^a   Lisi, S ^a   Maffione, A B ^a   Mitolo, V ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

18S rRNA; Cell Membrane Receptors; Chemokine Receptors; Conserved Sequences; Evolution; Formyl Peptide Receptors; Seven transmembrane Receptors; Viruses

Indexed keywords

AMYLOID BETA PROTEIN; CARBAMIC ACID DERIVATIVE; CHEMOKINE RECEPTOR; CHEMOTACTIC FACTOR; CHENODEOXYCHOLIC ACID; COMPLEMENT COMPONENT C5A; CYCLOSPORIN; DEOXYCHOLIC ACID; DIACYLGLYCEROL; F ACTIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; HISTIDYLPHENYLALANYLTYROSYLLEUCYLPROLYLMETHIONINAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LEUKOTRIENE B4; LIPOCORTIN 1; LIPOPOLYSACCHARIDE; LIPOXIN A; METHIONYLLEUCYLPHENYLALANINE; PERTUSSIS TOXIN; PHENYLALANYLLEUCYLPHENYLALANYLLEUCYLPHENYLALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA 18S; THROMBOCYTE ACTIVATING FACTOR; TRYPTOPHYLLYSYLTYROSYLVALYLMETHIONINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CALCIUM MOBILIZATION; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL STRAIN HEK293; CELL STRAIN HL 60; CELL STRAIN U937; CHEMOTAXIS; CHROMOSOME 19Q; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DENDRITIC CELL; ESCHERICHIA COLI; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INNATE IMMUNITY; INTERNALIZATION; LISTERIA MONOCYTOGENES; MAST CELL LEUKEMIA; MONONUCLEAR PHAGOCYTE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHOSPHORYLATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR DOWN REGULATION; RESPIRATORY BURST; SENILE PLAQUE; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION; XENOPUS;

HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY; NEURODEGENERATIVE DISEASES; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION;

ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LISTERIA MONOCYTOGENES;

EID: 33646706847     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970600625975     Document Type: Article

References (130)

1. Murphy, P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 1994, 12, 593-633.
2. Gerard, C.; Gerard, N.P. The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr. Opin. Immunol. 1994, 6, 140-145.
3. Schiffmann, E.; Corcoran B.A.; Wahl S.M. N-formylmethionyl peptides as chemoattractants for leukocytes. Proc. Natl. Acad. Sci. USA 1975, 72, 1059-1062.
4. Marasco, W.A.; Phan, S.H.; Krutzsch, H.; Showell, H.J.; Feltner, D.E.; Nairn, R.; Becker, E.L.; Ward, P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide nauthophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 1984, 259, 5430-5439.
5. Carp, H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 1982, 155, 264-275.
6. Bockaert, J.; Pin, J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999, 18, 1723-1729.
7. Gudermann, T.; Kalkbrenner, F.; Dippel, E.; Laugwitz, K.L.; Schultz, G. Specificity and complexity of receptor-G-protein interaction. Adv. Second Messenger Phosphoprotein. Res. 1997, 31, 253-262.
8. Haviland, D.L.; Borel, A.C.; Fleischer, D.T.; Haviland, J.C.; Wetsel, R.A. Structure, 5′-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation. Biochemistry 1993, 32, 4168-4174.
9. Boulay, F.; Tardif, M.; Brouchon, L.; Vignais, P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 1990, 168, 1103-1109.
10. Yang, D.; Chen, Q.; Le, Y.; Wang, J.M.; Oppenheim, J.J. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol. 2001, 166, 4092-4098.
11. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R.D.; Oppenheim, J.J. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukoc. Biol. 2002, 72, 598-607.
12. Migeotte, I.; Riboldi, E.; Franssen, J.D.; Grégoire, F.; Loison, C.; Wittamer, V.; Detheux, M.; Robberecht, P.; Costagliola, S.; Vassart, G.; Sozzani, S.; Parmentier, M., Communi, D. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 2005, 201, 83-93.
13. Ye, R.D.; Quehenberger, O.; Thomas, K.M.; Navarro, J.; Cavanagh, S.L.; Prossnitz, E.R.; Cochrane, C.G. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications. J. Immunol. 1993, 150, 1383-1394.
14. Snyderman, R.; Pike, M.C. N-Formylmethionyl peptide receptors on equine leukocytes initiate secretion but not chemotaxis. Science 1980, 209, 493-495.
15. Liang, T.S.; Wang, J.M.; Murphy, P.M.; Gao, J.L. Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils. Biochem. Biophys. Res. Commun. 2000, 270, 331-335.
16. Hartt, J.K.; Liang, T.; Sahagun-Ruiz, A.; Wang, J.M.; Gao, J.L.; Murphy, P.M. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor. Biochem. Biophys. Res. Commun. 2000, 272, 699-704.
17. Gao, J.L.; Lee, E.J.; Murphy P.M. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 1999, 189, 657-662.
18. Cui, Y.H.; Le, Y.; Gong, W.; Proost, P.; Van Damme, J.; Murphy, W.J.; Wang, J.M. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 2002b, 168, 434-442.
19. Lacy, M.; Jones, J.; Whittemore, S.R.; Haviland, D.L.; Wetsel, R.A.; Barnum, S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 1995, 61, 71-78.
20. 2- and cardiac dysfunctions in isolated perfused rat hearts. Arch. Toxicol. 1991, 65, 361-365.
21. Keitoku, M.; Kohzuki, M.; Katoh, H.; Funakoshi, M.; Suzuki, S.; Takeuchi, M.; Karibe, A.; Horiguchi, S.; Watanabe, J.; Satoh, S.; Nose, M.; Abe, K.; Okayama, H.; Shirato, K. FMLP actions and its binding sites in isolated human coronary arteries. J. Mol. Cell. Cardiol. 1997, 29, 881-894.
22. Panaro, M.A.; Mitolo, V. Cellular responses to FMLP challenging: a mini-review. Immunopharmacol. Immunotoxicol. 1999, 21, 397-419.
23. Becker, E.L.; Forouhar, F.A.; Grunnet, M.L.; Boulay, F.; Tardif, M.; Bormann, B.J.; Sodja, D.; Ye, R.D.; Woska, J.R. Jr.; Murphy, P.M. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 1998, 292, 129-135.
24. Müller-Ladner, U.; Jones, J.L.; Wetsel, R.A.; Gay, S.; Raine, C.S.; Barnum, S.R. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 1996, 144, 135-141.
25. Sozzani, S.; Sallusto, F.; Luini, W.; Zhou, D.; Piemonti, L.; Allavena, P.; Van Damme, J.; Valitutti, S.; Lanzavecchia, A.; Mantovani, A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 1995, 155, 3292-3295.
26. McCoy, R.; Haviland, D.L.; Molmenti, E.P.; Ziambaras, T.; Wetsel, R.A.; Perlmutter, D.H. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 1995, 182, 207-217.
27. VanCompernolle, S.E.; Clark, K.L.; Rummel, K.A.; Todd, S.C. Expression and function of formyl peptide receptors on human fibroblast cells. J. Immunol. 2003, 171, 2050-2056.
28. Klinker, J.F.; Schwaner, I.; Offermanns, S.; Hageluken, A.; Seifert, R. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants. Biochem. Pharmacol. 1994, 48, 1857-1864.
29. Wenzel-Seifert, K.; Seifert, R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L- phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.J. Immunol. 1993, 150, 4591-4599.
30. Seifert, R.; Wenzel-Seifert, K. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors. Life Sci. 2003, 73, 2263-2280.
31. i-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. J. Biol. Chem. 1989, 264, 21470-21473.
32. 2+ and in membrane potential of human neutrophils. J. Biol. Chem. 1986, 261, 9710-9713.
33. 2+ signal neutrophil chemotaxis in response to formylated chemotactic peptide? J. Cell. Sci. 1995, 108, 3199-3205.
34. Boitano, S.; Dirksen, E.R.; Sanderson, M.J. Intercellular propagation of calcium waves mediated by inositol trisphosphate. Science. 1992, 258, 292-295.
35. Traynor-Kaplan, A.E.; Harris, A.L.; Thompson, B.L.; Taylor, P.; Sklar, L.A. An inositol tetrakisphosphate-containing phospholipid in activated neutrophils. Nature. 1988, 334, 353-356.
36. Browning, D.D.; Pan, Z.K.; Prossnitz, E.R.; Ye, R.D. Cell type-and developmental stage-specific activation of NF-κB by fMet-Leu-Phe in myeloid cells. J. Biol. Chem. 1977, 272, 7995-8001.
37. Pan, Z.K.; Chen, L.Y.; Cochrane, C.G.; Zuraw, B.L. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: the role of phosphatidylinositol 3-kinase. J. Immunol. 2000, 164, 404-411.
38. Sadhu, C.; Masinovsky, B.; Dick, K.; Sowell, C.G.; Staunton, D.E. Essential role of phosphoinositide 3-kinase δ in neutrophil directional movement. J. Immunol. 2003, 170, 2647-2654.
39. 2 modulates respiratory burst developed by neutrophils in patients with rheumatoid arthritis. J. Cell. Mol. Med. 2003, 7, 57-66.
40. 2 with anti-inflammatory activity. Pharmacol. Exp. Ther. 1997, 282, 123-131.
41. 2-dependent selective release of arachidonic acid by fMLP-stimulated rat neutrophils. FEBS Lett. 1996, 395, 293-298.
42. 2 inhibitors on the formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis of human leukocytes in vitro. Arzneimittelforschung. 1998, 48, 77-81.
43. English, D. Phosphatidic acid: a lipid messenger involved in intracellular and extracellular signalling. Cell. Signal. 1996, 8, 341-347.
44. Yasui, K.; Komiyama A. Roles of phosphatidylinositol 3-kinase and phospholipase D in temporal activation of superoxide production in FMLP-stimulated human neutrophils. Cell. Biochem. Funct. 2001, 19, 43-50.
45. phox phosphorylation. J. Biol. Chem. 2000, 275, 28406-28412.
46. Pillinger, M.H.; Feoktistov, A.S.; Capodici, C.; Solitar, B.; Levy, J.; Oei, T.T.; Philips, M.R. Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell-cell adhesion. J. Biol. Chem. 1996, 271, 12049-12056.
47. Knall, C.; Young, S.; Nick, J.A.; Buhl, A.M.; Worthen, G.S.; Johnson, G.L. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 1996, 271, 2832-2838.
48. Krump, E.; Sanghera, J.S.; Pelech, S.L.; Furuya, W.; Grinstein, S. Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J. Biol. Chem. 1997, 272, 937-944.
49. Worthen, G.S.; Avdi, N.; Buhl, A.M.; Suzuki, N.; Johnson, G.L. FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase. J. Clin. Invest. 1994, 94, 815-823.
50. Avdi, N.J.; Winston, B.W.; Russel, M.; Young, S.K.; Johnson, G.L.; Worthen, G.S. Activation of MEKK by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Mapping pathways for mitogen-activated protein kinase activation. J. Biol. Chem. 1996, 271, 33598-33606.
51. Nick, J.A.; Avdi, N.J.; Young, S.K.; Knall, C.; Gerwins, P.; Johnson, G.L.; Worthen, G.S. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 1997, 99, 975-986.
52. Rane, M.J.; Arthur, J.M.; Prossnitz, E.R.; McLeish, K.R. Activation of mitogen-activated protein kinases by formyl peptide receptors is regulated by the cytoplasmic tail. J. Biol. Chem. 1998, 273, 20916-20923.
53. Huang, S.; Chen, L.Y.; Zuraw, B.L.; Ye, R.D.; Pan, Z.K. Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA. J. Biol. Chem. 2001, 276, 40977-40981.
54. Chen, L.Y.; Doerner, A.; Lehmann, P.F.; Huang, S.; Zhong, G.; Pan, Z.K. A novel protein kinase C (PKCe) is required for fMet-Leu-Phe induced activation of NF-B in human peripheral blood monocytes. J. Biol. Chem. 2005, 280, 22497-22501.
55. Bae, Y.S.; Park, E.Y.; Kim, Y.; He, R.; Ye, R.D.; Kwak, J.Y.; Suh, P.G.; Ryu, S.H. Novel chemoattractant peptides for human leukocytes. Biochem. Pharmacol. 2003, 66, 1841-1851.
56. Le, Y.; Gong, W.; Li, B.; Dunlop, N.M.; Shen, W.; Su, S.B.; Ye, R.D.; Wang, J.M. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 1999, 163, 6777-6784.
57. Hu, J.Y.; Le, Y.; Gong, W.; Dunlop, N.M.; Gao, J.L.; Murphy, P.M.; Wang, J.M. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukoc. Biol. 2001, 70, 155-161.
58. Fabbri, E.; Spisani, S.; Barbin, L.; Biondi, C.; Buzzi, M.; Traniello, S.; Zecchini, G.P.; Ferretti, M.E. Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues. Cell. Signal. 2000, 12, 391-398.
59. Cavicchioni, G.; Turchetti, M.; Spisani, S. Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2. J. Pept. Res. 2002, 60, 223-231.
60. Cavicchioni, G.; Turchetti, M.; Varani, K.; Falzarano, S.; Spisani, S. Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide. Bioorg. Chem. 2003, 31, 322-330.
61. Su, S.B.; Gong, W.H.; Gao, J.L.; Shen, W.P.; Grimm, M.C.; Deng, X.; Murphy, P.M.; Oppenheim, J.J.; Wang, J.M. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 1999a, 93, 3885-3892.
62. Su, S.B.; Gong, W.; Gao, J.L.; Shen, W.; Murphy, P.M.; Oppenheim, J.J.; Wang, J.M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999b, 189, 395-402.
63. Le, Y.; Jiang, S.; Hu, J.; Gong, W.; Su, S.; Dunlop, N.M.; Shen, W.; Li, B.; Ming Wang, J. N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes. Clin. Immunol. 2000, 96, 236-242.
64. Bylund, J.; Christophe, T.; Boulay F.; Nystrom, T.; Karlsson, A.; Dahlgren, C. Proinflammatory activity of a cecropin-like antibacterial peptide from Helicobacter pylori. Antimicrob. Agents Chemother. 2001, 45, 1700-1704.
65. Betten, A.; Bylund, J.; Cristophe, T.; Boulay, F.; Romero, A.; Hellstrand, K.; Dahlgren, C. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Invest. 2001, 108, 1221-1228.
66. Walther, A.; Riehemann, K.; Gerke, V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 2000, 5, 831-840.
67. Ernst, S.; Lange, C.; Wilbers, A.; Goebeler, V.; Gerke, V.; Rescher, U. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J. Immunol. 2004, 172, 7669-7676.
68. Cui, Y.; Le, Y.; Yazawa, H.; Gong, W.; Wang, J.M. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 2002a, 72, 628-635.
69. 42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 2001a, 21, RC123.
70. Le, Y.; Yazawa, H.; Gong, W.; Yu, Z.; Ferrans, V.J.; Murphy, P.M.; Wang, J.M. The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 2001b, 166, 1448-1451.
71. Gao, J.L.; Becker, E.L.; Freer, R.J.; Muthukumaraswamy, N.; Murphy, P.M. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J. Exp. Med. 1994, 180, 2191-2197.
72. rd; Bridger, G.J.; Derian, C.K.; Beblavy, M.J.; Hernandez, P.E.; Gaul, F.E.; Abrams, M.J.; Pike, M.C.; Solomon, H.F. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. J. Med. Chem. 1996, 39, 1013-1015.
73. Freer, R.J.; Day, A.R.; Radding, J.A.; Schiffmann, E.; Aswanikumar, S.; Showell, H.J.; Becker, E.L. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry 1980, 19, 2404-2410.
74. Dalpiaz, A.; Ferretti, M.E.; Pecoraro, R.; Fabbri, E.; Traniello, S.; Scatturin, A.; Spisani, S. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects. Biochim. Biophys. Acta 1999, 1432, 27-39.
75. Wenzel-Seifert, K.; Grunbaum, L.; and Seifert, R. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation. J. Immunol. 1991, 147, 1940-1946.
76. rd; Beblavy, M.J.; Santulli, R.J.; Bridger, G.J.; Pike, M.C.; Kroon, D.J.; Fischman, A.J. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. Biochemistry 1996, 35, 1265-1269.
77. Chen, X.; Yang, D.; Shen, W.; Dong, H.F.; Wang, J.M.; Oppenheim, J.J.; Howard, M.Z. Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors. Inflamm. Res. 2000, 49, 744-755.
78. Chen, X.; Mellon, R.D.; Yang, L.; Dong, H.; Oppenheim, J.J.; Howard, O.M. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractant. Biochem. Pharmacol. 2002, 63, 533-541.
79. Ali, H.; Richardson, R.M.; Haribabu, B.; Snyderman, R. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 1999, 274, 6027-6030.
80. Prossnitz, E.R.; Ye, R.D. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 1997a, 74, 73-102.
81. Prossnitz, E.R. Desensitization of N-formylpeptide receptor-mediated activation is dependent upon receptor phosphorylation. J. Biol. Chem. 1997b, 272, 15213-15219.
82. Hsu, M.H.; Chiang, S.C.; Ye, R.D.; Prossnitz, E.R. Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis. J. Biol. Chem. 1997, 272, 29426-29429.
83. Tomhave, E.D.; Richardson, R.M.; Didsbury, J.R.; Menard, L.; Snyderman, R.; Ali, H. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J. Immunol. 1994, 153, 3267-3275.
84. Didsbury, J.R.; Uhing, R.J.; Tomhave, E.; Gerard, C.; Gerard, N.; Snyderman, R. Receptor Class Desensitization of Leukocyte Chemoattractant Receptors. Proc. Natl. Acad. Sci. USA 1991, 88, 1564-1568.
85. Richardson, R.M.; DuBose, R.A.; Ali, H.; Tomhave, E.D.; Haribabu, B.; Snyderman, R. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions. Biochemistry. 1995a, 34, 14193-14201.
86. Richardson, R.M.; Ali, H.; Tomhave, E.D.; Haribabu, B.; Snyderman, R. Cross-desensitization of Chemoattractant Receptors Occurs at Multiple Levels. J. Biol. Chem. 1995b, 270, 27829-27833.
87. Watts, R.G.; Crispens, M.A.; Howard, T.H. A quantitative study of the role of F-actin in producing neutrophil shape. Cell. Motil. Cytoskeleton. 1991, 19, 159-168.
88. Fernandez-Segura, E.; Garcia, J.M.; Santos, J.L.; Campos, A. Shape, F-actin, and surface morphology changes during chemotactic peptide-induced polarity in human neutrophils. Anat. Rec. 1995, 241, 519-528.
89. Calvello, R.; Saccia, M.; Maffione, A.B.; Panaro, M.A.; Mitolo, V. Power spectral analysis of the shape of fMLP-stimulated granulocytes. A tool for the study of cytoskeletal organization under normal and pathological conditions. Immunopharmacol. Immunotoxicol. 2002, 24, 139-163.
90. Arbour, N.; Tremblay, P.; Oth, D. N-formyl-methionyl-leucyl-phenylalanine induces and modulates IL-1 and IL-6 in human PBMC. Cytokine 1996, 8, 468-475.
91. Sen, R.; Baltimore, D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986, 47, 921-928.
92. Baeuerle, P.A.; Henkel, T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12, 141-179.
93. Ye, R.D.; Boulay, F. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 1997, 39, 221-289.
94. nd.
95. Gwinn, M.R.; Sharma, A.; De Nardin, E. Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis. J. Periodontol. 1999, 70, 1194-1201.
96. Sipe, J.D. The acute-phase response. In Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation; Oppenheim, J.J., Shevach, E.M., Eds.; Oxford University Press: New York, 1990; 259-273.
97. Badolato, R.; Wang, J.M.; Murphy, W.J.; Lloyd, A.R.; Michiel, D.F.; Bausserman, L.L.; Kelvin, D.J.; Oppenheim, J.J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 1994, 180, 203-209.
98. Kisilevsky, R. Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism. Med. Hypotheses. 1991, 35, 337-341.
99. Malle, E.; De Beer, F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 1996, 26, 427-435.
100. Glenner, G.G. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N. Engl. J. Med. 1980, 302, 1333-1343.
101. Stone, M.J. Amyloidosis: a final common pathway for protein deposition in tissues. Blood. 1990, 75, 531-545.
102. Lorton, D.; Schaller, J.; Lala, A.; De Nardin, E. Chemotactic-like receptors and Aβ peptide indvuced responses in Alzheimer's disease. Neurobiol. Aging. 2000, 21, 463-473.
103. Davis, J.B.; McMurray, H.F.; Schubert, D. The amyloid β-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 1992, 189, 1096-1100.
104. El Khoury, J.; Hickman, S.E.; Thomas, C.A.; Cao, L.; Silverstein, S.C.; Loike, J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 1996, 382, 716-719.
105. Yan, S.D.; Chen, X.; Fu, J.; Chen, M.; Zhu, H.; Roher, A.; Slattery, T.; Zhao, L.; Nagashima, M.; Morser, J.; Migheli, A.; Nawroth, P.; Stern, D.; Schmidt, A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 1996, 382, 685-691.
106. Nakai, M.; Hojo, K.; Taniguchi, T.; Terashima, A.; Kawamata, T.; Hashimoto, T.; Maeda, K.; Tanaka, C. PKC and tyrosine kinase involvement in amyloid beta (25-35)-induced chemotaxis of microglia. Neuroreport 1998, 9, 3467-3470.
107. Scali, C.; Prosperi, C.; Giovannelli, L.; Bianchi, L.; Pepeu, G.; Casamenti, F. β(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo. Brain Res. 1999, 831, 319-321.
108. Combs, C.K.; Johnson, D.E.; Cannady, S.B.; Lehman, T.M.; and Landreth, G.E. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins. J. Neurosci. 1999, 19, 928-939.
109. Kopec, K.K.; Carroll, R.T. Alzheimer's β-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J. Neurochem. 1998, 71, 2123-2131.
110. Bonaiuto, C.; McDonald, P.P.; Rossi, F.; Cassatella, M.A. Activation of nuclear factor-κB by β-amyloid peptides and interferon-γ in murine microglia. J. Neuroimmunol. 1997, 77, 51-56.
111. Klegeris, A.; McGeer, P.L. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 1997a, 49, 229-235.
112. Klegeris, A.; Walker, D.G.; McGeer, P.L. Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α. Brain Res. 1997b, 747, 114-121.
113. Fiala, M.; Zhang, L.; Gan, X.; Sherry, B.; Taub, D.; Graves, M.C.; Hama, S.; Way, D.; Weinand, M.; Witte, M.; Lorton, D.; Kuo, Y.M.; Roher, A.E. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol. Med. 1998, 4, 480-489.
114. Zhang, C.; Qiu, H.E.; Krafft, G.A.; Klein, W.L. Protein kinase C and F-actin are essential for stimulation of neuronal FAK tyrosine phosphorylation by G-proteins and amyloid beta protein. FEBS Lett. 1996, 386, 185-188.
115. McDonald, D.R.; Brunden, K.R.; Landreth, G.E., Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 1997, 17, 2284-2294.
116. McDonald, D.R.; Bamberger, M.E.; Combs, C.K.; Landreth, G.E. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 1998, 18, 4451-4460.
117. 42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 2001, 15, 2454-2462.
118. Peyrin, J.M.; Lasmezas, C.I.; Haik, S.; Tagliavini, F.; Salmona, M.; Williams, A.; Richie, D.; Deslys, J.P.; Dormont D. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport. 1999, 10, 723-729.
119. Deng, X.; Ueda, H.; Su, S.B.; Gong, W.; Dunlop, N.M.; Gao, J.L.; Murphy, P.M.; Wang, J.M. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood 1999, 94, 1165-1173.
120. Wang, J.M.; Ueda, H.; Howard, O.M.; Grimm, M.C.; Chertov, O.; Gong, X.; Gong, W.; Resau, J.H.; Broder, C.C.; Evans, G.; Arthur, L.O.; Ruscetti, F.W.; Oppenheim, J.J. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation. J. Immunol. 1998, 161, 4309-4317.
121. Ueda, H.; Howard, O.M.; Grimm, M.C.; Su, S.B.; Gong, W.; Evans, G.; Ruscetti, F.W.; Oppenheim, J.J.; Wang, J.M. HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes. J. Clin. Invest. 1998, 102, 804-812.
122. Le, Y.; Oppenheim, J.J.; Wang, J.M. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001c, 12, 91-105.
123. Nara, P.L.; Garrity, R.R.; Goudsmit, J. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. 1991, 5, 2437-2455.
124. Hattori, T.; Komoda, H.; Pahwa, S.; Tateyama, M.; Zhang, X.; Xu, Y.; Oguma, S.; Tamamura, H.; Fujii, N.; Fukutake, K.; Uchiyama, T. Decline of anti-DP107 antibody associated with clinical progression. AIDS. 1998, 12, 1557-1559.
125. Kilby, J.M.; Hopkins, S.; Venetta, T.M.; DiMassimo, B.; Cloud, G.A.; Lee, J.Y.; Alldredge, L.; Hunter, E.; Lambert, D.; Bolognesi, D.; Matthews, T.; Johnson, M.R.; Nowak, M.A.; Shaw, G.M.; Saag, M.S. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 1998, 4, 1302-1307.
126. Rimsky, L.T.; Shugars, D.C.; Matthews, T.J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 1998, 72, 986-993.
127. Le, Y.; Yang, Y.; Cui, Y.; Yazawa, H.; Gong, W.; Qiu, C.; Wang, J.M. Receptors for chemotactic formyl peptides as pharmacological targets. Int. Immunopharmacol. 2002, 2, 1-13.
128. Shen, W.; Li, B.; Wetzel, M.A.; Rogers, T.J.; Henderson, E.E.; Su, S.B.; Gong, W.; Le, Y. Sargeant, R. Dimitrov, D.S., Oppenheim, J.J. and Wang, J.M. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes. Blood 2000a, 96, 2887-2894.
129. Horuk, R. In Encyclopedic reference of molecular pharmacology; Offermanns, S., Rosenthal, W., Eds.; Springer-Verlag: Berlin Heidelberg, 2004; 237-241.
130. Shen, W.; Proost, P.; Li, B.; Gong, W.; Le, Y.; Sargeant, R.; Murphy, P.M.; Van Damme, J.; Wang, J.M. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Biochem. Biophys. Res. Commun. 2000b, 272, 276-283.